Barry M. Zee

4.0k total citations
42 papers, 2.6k citations indexed

About

Barry M. Zee is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, Barry M. Zee has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Spectroscopy. Recurrent topics in Barry M. Zee's work include Genomics and Chromatin Dynamics (22 papers), Epigenetics and DNA Methylation (21 papers) and Ubiquitin and proteasome pathways (10 papers). Barry M. Zee is often cited by papers focused on Genomics and Chromatin Dynamics (22 papers), Epigenetics and DNA Methylation (21 papers) and Ubiquitin and proteasome pathways (10 papers). Barry M. Zee collaborates with scholars based in United States, Germany and United Kingdom. Barry M. Zee's co-authors include Benjamin A. García, Gary LeRoy, Nicolas L. Young, Peter A. DiMaggio, Rebecca S. Levin, Mitzi I. Kuroda, Michelle Gonzales-Cope, Andrés Blanco, Artyom A. Alekseyenko and Benjamin A. Garcia and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Barry M. Zee

41 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry M. Zee United States 24 2.3k 223 201 187 168 42 2.6k
Catherine A. Musselman United States 31 2.6k 1.1× 71 0.3× 219 1.1× 150 0.8× 101 0.6× 50 2.9k
Skylar Martin‐Brown United States 14 1.5k 0.6× 110 0.5× 139 0.7× 123 0.7× 106 0.6× 16 1.7k
Alessandro Cuomo Italy 24 1.8k 0.8× 91 0.4× 350 1.7× 150 0.8× 250 1.5× 48 2.3k
Karen Colwill Canada 22 2.3k 1.0× 210 0.9× 281 1.4× 184 1.0× 132 0.8× 55 2.9k
Y. Muto Japan 26 2.1k 0.9× 98 0.4× 178 0.9× 154 0.8× 98 0.6× 92 2.3k
John LaCava United States 21 2.2k 0.9× 82 0.4× 100 0.5× 109 0.6× 194 1.2× 49 2.5k
Michael S. Cosgrove United States 22 1.9k 0.8× 50 0.2× 134 0.7× 146 0.8× 66 0.4× 36 2.2k
H. Christian Eberl Germany 17 1.5k 0.6× 171 0.8× 130 0.6× 118 0.6× 99 0.6× 27 1.7k
Shankha Satpathy Denmark 13 1.1k 0.5× 219 1.0× 220 1.1× 79 0.4× 169 1.0× 24 1.4k
Zhen‐Yuan Lin Canada 21 2.1k 0.9× 161 0.7× 295 1.5× 284 1.5× 166 1.0× 30 2.6k

Countries citing papers authored by Barry M. Zee

Since Specialization
Citations

This map shows the geographic impact of Barry M. Zee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry M. Zee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry M. Zee more than expected).

Fields of papers citing papers by Barry M. Zee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry M. Zee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry M. Zee. The network helps show where Barry M. Zee may publish in the future.

Co-authorship network of co-authors of Barry M. Zee

This figure shows the co-authorship network connecting the top 25 collaborators of Barry M. Zee. A scholar is included among the top collaborators of Barry M. Zee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry M. Zee. Barry M. Zee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blazev, Ronnie, Barry M. Zee, Chengxin Zhang, et al.. (2025). Site-specific quantification of the in vivo UFMylome reveals myosin modification in ALS. Cell Reports Methods. 5(5). 101048–101048.
2.
Jiao, Alan, et al.. (2024). An E2 ubiquitin-conjugating enzyme links diubiquitinated H2B to H3K27M oncohistone function. Proceedings of the National Academy of Sciences. 121(48). e2416614121–e2416614121. 1 indexed citations
3.
Zee, Barry M., et al.. (2022). Variant Polycomb complexes in Drosophila consistent with ancient functional diversity. Science Advances. 8(36). eadd0103–eadd0103. 14 indexed citations
4.
Jung, Youngsook L., Kyle A. McElroy, Barry M. Zee, et al.. (2017). Bivalent complexes of PRC1 with orthologs of BRD4 and MOZ/MORF target developmental genes in Drosophila. Genes & Development. 31(19). 1988–2002. 22 indexed citations
5.
Zee, Barry M., et al.. (2016). The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns. PLoS ONE. 11(10). e0163820–e0163820. 21 indexed citations
6.
Won, Kyoung‐Jae, Inchan Choi, Gary LeRoy, et al.. (2015). Proteogenomics analysis reveals specific genomic orientations of distal regulatory regions composed by non-canonical histone variants. Epigenetics & Chromatin. 8(1). 13–13. 8 indexed citations
7.
Alekseyenko, Artyom A., Andrey A. Gorchakov, Barry M. Zee, et al.. (2014). Heterochromatin-associated interactions of Drosophila HP1a with dADD1, HIPP1, and repetitive RNAs. Genes & Development. 28(13). 1445–1460. 67 indexed citations
8.
Stadler, Sonja C., C. Vincent, V D Fedorov, et al.. (2013). Correction for Stadler et al., Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells. Proceedings of the National Academy of Sciences. 110(40). 16283–16283. 3 indexed citations
9.
LeRoy, Gary, Iouri Chepelev, Peter A. DiMaggio, et al.. (2012). Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins. Genome biology. 13(8). R68–R68. 72 indexed citations
10.
Voigt, Philipp, Gary LeRoy, William J. Drury, et al.. (2012). Asymmetrically Modified Nucleosomes. Cell. 151(1). 181–193. 317 indexed citations
11.
Blanco, Andrés, Gary LeRoy, Zia Khan, et al.. (2012). Global secretome analysis identifies novel mediators of bone metastasis. Cell Research. 22(9). 1339–1355. 84 indexed citations
12.
Zee, Barry M., et al.. (2012). Origins and Formation of Histone Methylation across the Human Cell Cycle. Molecular and Cellular Biology. 32(13). 2503–2514. 64 indexed citations
13.
Zee, Barry M. & Benjamin A. Garcia. (2012). Validation of Protein Acetylation by Mass Spectrometry. Methods in molecular biology. 981. 1–11. 8 indexed citations
14.
Zee, Barry M., Nicolas L. Young, & Benjamin A. García. (2011). Quantitative Proteomic Approaches to Studying Histone Modifications. PubMed. 5(Suppl 1). 106–114. 12 indexed citations
15.
Gonzales-Cope, Michelle, et al.. (2011). Breaking the histone code with quantitative mass spectrometry. Expert Review of Proteomics. 8(5). 631–643. 95 indexed citations
16.
Wu, Lipeng, Barry M. Zee, Yanming Wang, Benjamin A. Garcia, & Yali Dou. (2011). The RING Finger Protein MSL2 in the MOF Complex Is an E3 Ubiquitin Ligase for H2B K34 and Is Involved in Crosstalk with H3 K4 and K79 Methylation. Molecular Cell. 43(1). 132–144. 135 indexed citations
17.
Kuo, Alex, Peggie Cheung, Kaifu Chen, et al.. (2011). NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming. Molecular Cell. 44(4). 609–620. 322 indexed citations
18.
Weiß, Thomas S., Sonja Hergeth, Ulrike Zeißler, et al.. (2010). Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D. Epigenetics & Chromatin. 3(1). 7–7. 86 indexed citations
19.
Zee, Barry M., Rebecca S. Levin, Bo Xu, et al.. (2009). In Vivo Residue-specific Histone Methylation Dynamics. Journal of Biological Chemistry. 285(5). 3341–3350. 203 indexed citations
20.
LeRoy, Gary, John T. Weston, Barry M. Zee, et al.. (2009). Heterochromatin Protein 1 Is Extensively Decorated with Histone Code-like Post-translational Modifications. Molecular & Cellular Proteomics. 8(11). 2432–2442. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026